October 1, 2025 · Form 4 insider transaction
Pizzuti Dana bought 5,000 shares of Crinetics Pharmaceuticals, Inc. at $16.89 per share, a transaction worth $84.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
On September 4, 2025, the Reporting Person filed a Form 4 (the "Prior Form 4") which inadvertently reported that, following the transactions reported in the Prior Form 4, the Reporting Person directly owned 96,270 shares of the Issuer's common stock. In fact, the Reporting Person directly owned 66,270 shares of the Issuer's common stock following the transactions reported in the Prior Form 4.